The resident, identified only as Resident 1, has dementia and chronic pain in the left hip and lumbar spine. During the final week of November, the patient received morphine six times over four days for pain levels ranging from 6 to 9 out of 10.
On November 22, staff administered morphine at 11:20 AM when the resident reported pain at 9 out of 10 — the scale's second-highest level, indicating nearly unbearable suffering.
The next day brought no relief. Staff gave morphine twice: once at 8:35 AM for pain rated 8 out of 10, then again at 5:48 PM when pain spiked back to 9 out of 10.
November 24 proved the worst day. The resident required three separate morphine doses — at 8:40 AM for 9 out of 10 pain, at 11:19 AM for 8 out of 10, and at 9:32 PM for 7 out of 10.
Only on November 25 did the pattern break, with a single morning dose for pain rated 6 out of 10.
Federal inspectors discovered the root cause during interviews with facility staff. The MDS nurse — responsible for coordinating resident care assessments — admitted that an order for diclofenac had been "missed." Diclofenac is an anti-inflammatory medication commonly prescribed for chronic joint and spine pain.
The nurse explained that the missed diclofenac "could have helped with Resident 1's pain relief."
Inspectors observed telling behavioral signs during their visit. The resident was holding their left leg, which the MDS nurse identified as a classic pain response called "guarding" — protecting the area that hurts.
This physical behavior became crucial evidence because, as the nurse explained to inspectors, "residents with dementia may not always be able to verbally report pain."
The resident's medical history reveals why consistent pain management matters so critically. Resident 1 lives with both dementia and documented chronic conditions affecting the left hip and lumbar spine that cause ongoing pain and stiffness.
For patients with these dual challenges — cognitive impairment and chronic pain — preventive medication becomes essential. When anti-inflammatory drugs like diclofenac work consistently, they can prevent pain from escalating to emergency levels requiring powerful opioids like morphine.
The facility's own policies acknowledge this responsibility. Royal Oaks Manor's hospice program guidelines, revised in July 2017, state that the facility must "meet the resident's personal care and nursing needs" and "ensure that the level of care provided is appropriately based on the individual resident's needs."
Those responsibilities explicitly include "administering prescribed therapies."
The medication administration records paint a stark picture of what happens when prescribed therapies go missing. Instead of receiving daily diclofenac to manage chronic inflammation, Resident 1 endured a cycle of severe pain episodes requiring reactive morphine doses.
Each morphine administration represents a moment when staff recognized the resident was suffering at levels between 6 and 9 out of 10 — pain severe enough to interfere with basic activities and sleep.
The timing pattern suggests the resident experienced breakthrough pain despite morphine's temporary relief. Pain returned within hours, requiring repeated emergency interventions rather than the steady management that daily diclofenac should have provided.
Federal inspectors classified this as a medication error affecting "some" residents with "minimal harm or potential for actual harm." But the classification doesn't capture the daily reality for Resident 1 — days of severe pain that could have been prevented.
The case illustrates broader challenges in dementia care, where residents cannot always articulate their suffering clearly. Staff must rely on behavioral cues like guarding, changes in activity levels, or increased agitation to recognize pain.
When prescribed medications go unadministered, these vulnerable residents bear the consequences in ways they may not be able to communicate effectively.
For Resident 1, the missed diclofenac order meant experiencing the kind of severe pain that registers 9 out of 10 on standard scales — described in medical literature as pain that dominates awareness and severely limits function.
The resident continues living with dementia and chronic hip and spine conditions. Whether the diclofenac order has since been corrected remains unclear from available records.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Royal Oaks Manor-bradbury Oaks from 2025-12-01 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Royal Oaks Manor-bradbury Oaks
- Browse all CA nursing home inspections